N-Methyl-4-(tributylstannyl)imidazole

BirdoTech, established in 2015, manufactures pharmaceutical intermediates and fine chemicals and provides outsourcing, custom synthesis and consulting services, selling to markets across North and South America, Western and Eastern Europe, Australasia, Asia, the Middle East and Africa. The company offers CRO, CMO and CDMO contract services under its own brand, and is recognized for its brand name, international approvals, experienced R&D staff, production capacity, broad product line and acceptance of both small orders and buyer-specific requirements.